BioLife Solutions, Inc.

02/18/2026

Will you be at the ScaleReady G-Rex Grant Tour stop in Philadelphia tomorrow, February 19?

Stop by the BioLife table to say hello to Andrew Sabatier. Whether you are scaling up from R&D, navigating clinical trials, or optimizing cryopreservation protocols for commercial production, Andrew can help you find a solution and take advantage of our exclusive G-Rex Grant Recipient offers.

🔔 Event details: https://www.scaleready.com/concepts/g-rex-grant-tour-philadelphia-pa/

See you soon in the city that “loves you back”! 💙🧡

02/17/2026

BioLife Solutions to Report Fourth Quarter and Full Year 2025 Financial Results and Business Update on February 26, 2026

https://investors.biolifesolutions.com/2026-02-17-BioLife-Solutions-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Business-Update-on-February-26,-2026

02/13/2026

Drug Discovery News discusses how the UK’s competitive edge in cell and gene therapy (CGT) is shifting from scientific discovery to industrial scale and ex*****on.

As more therapies move toward clinical use and commercial approval, manufacturing scalability, automation, supportive policy, and funding architecture are becoming the decisive factors. 🧪⚙️

BioLife’s Chief Technology Officer, Sean Werner, comments on the necessity of automation in CGT manufacturing and the difference in cost reductions of allogeneic vs autologous therapies.

If these factors align, the UK is positioned to evolve from a research leader into a globally competitive manufacturing and delivery hub for advanced therapies. 📈

💡 Find out how the UK CGT sector is pushing momentum forward: https://www.drugdiscoverynews.com/can-manufacturing-turn-uk-cell-and-gene-therapy-strength-into-scale-16981

02/12/2026

BioLife Solutions Signs Multi-Year Supply Agreement with Qkine Limited to Expand its Product Portfolio into the Rapidly Growing Cytokines Market

BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year...

02/11/2026

ISCT is hosting two “Hands-on Laboratory Bootcamp for Cell Therapy Biomanufacturing” sessions. 🥾🧬

Stanford University School of Medicine: March 23-27

Georgia Tech: September 14-18

If you or your team are looking for lab training with an extensive overview of cell therapy manufacturing processes, then sign up for either the spring or fall sessions soon. Participants will learn the following: aseptic technique, cleanroom operations, T-cell expansion, QC testing, product harvest, release criteria, and documentation practices. 👩‍🔬👨‍🔬

BioLife is thrilled to support these Lab Bootcamps by providing biopreservation media and a presentation on Monday, March 23, during the Stanford Lunch & Learn event.

📍 Stanford Signup: https://www.isctglobal.org/workforce-development/hands-on-laboratory-bootcamp-for-cell-therapy-biomanufacturing-stanford-lcgm

📍 GA Tech Signup: https://www.isctglobal.org/workforce-development/hands-on-laboratory-bootcamp-for-cell-therapy-biomanufacturing

Video Credit: Stanford Laboratory for Cell and Gene Medicine
https://youtu.be/l3gs7MJXsRU?si=S-rK5VwQghJmHrpS

02/05/2026

BioLife Solutions will be participating in the ScaleReady G-Rex Grant Tour stop in Philadelphia on Thursday, February 19 – exactly two weeks away. 🔔

This month Andrew Sabatier and Steve Scott will be onsite at the BioLife table. They are looking forward to sharing industry insights, biopreservation best practices, building relationships, and helping move the CGT industry forward to better serve patients.

We’re proud to support the Emily Whitehead Foundation, ScaleReady, and all G-Rex grant recipients on this year-long tour. 🤝

🔶 Check out the speaker lineup, agenda, and register now: https://www.scaleready.com/concepts/g-rex-grant-tour-philadelphia-pa/

Do you know a CGT researcher who could benefit from the G-Rex Grant Program?

🔶 Share this page with them: https://www.scaleready.com/concepts/g-rex-grant-program/

02/03/2026

Phacilitate Advanced Therapies Week 2026 is less than ONE week away!

I don’t know about you, but we’re ready to head to sunny San Diego and get out of the cold or snowy weather many of us have been experiencing across the US. 🌅🌴

Stop by booth 420 to reconnect with your favorite team members or say hello for the first time. Todd Berard, Sandy Jones, Bill Yang, Vicky Tran, Andrew Sabatier, and Amy Ma will be onsite.

We can’t wait for you to see our refreshed booth, product displays, and new SWAG giveaways. 😎

Review the agenda: https://www.phacilitate.com/advanced-therapies-week-agenda

🔬 Are you a therapeutic/drug developer with an active clinical or pre-clinical pipeline? Request your FREE pass here: https://ow.ly/FAoJ50XSLxv

01/29/2026

Are you hearing more about Transient Warming Events in the Cell and Gene Therapy ecosystem?

♨️ A Transient Warming Event (TWE) occurs when a cryopreserved sample is exposed to warmer-than-intended temperatures for any period of time, including the time it takes to remove a sample from the freezer. A temperature excursion like this might seem insignificant at first, but even brief exposure to higher temperatures can compromise the integrity of the frozen cells post-thaw.

♨️ In the latest Cytotherapy journal, Canadian Blood Services and Robert Ben of Panthera CryoSolutions (part of BioLife Solutions), explore TWEs and how different cryosolutions can impact stem cell grafts.

♨️ The study identifies ice recrystallization during warming as a dominant mechanism of cryoinjury and shows that the addition of ice recrystallization inhibitors (IRI) can effectively mitigate TWE-induced damage.

📑Read on: https://www.isct-cytotherapy.org/article/S1465-3249(25)00903-X/abstract

01/28/2026

The cryopreservation success of cell-based materials may be limited by ice recrystallization, a major and under-represented source of cryoinjury. 💥

How can you address ice recrystallization?

🔎 In a November 2025 feature with Engineering & Biotechnology News, the Panthera CryoSolutions (part of BioLife Solutions) team, shared a tutorial on ice recrystallization inhibitor (IRI) technology.

❄️ Synthetic IRIs, developed to mimic antifreeze protein activity without associated toxicity or ice-shaping artifacts, can prevent ice crystal growth.

❄️ Data across multiple cell types and tissues show that incorporating IRIs into cryopreservation processes can improve post-thaw viability, functional recovery, and resilience to temperature excursions.

Review the tutorial below to learn about the science behind IRIs, and why you should consider incorporating them into your existing biopreservation workflow. 👇

https://www.genengnews.com/topics/translational-medicine/targeting-ice-recrystallization-to-improve-cryopreservation-consistency/

01/22/2026

Are you ready for a new Phacilitate Advanced Therapies Week experience? 😎🏖️

Join us on February 9-12 in one of the fastest growing biotech hubs – San Diego, CA. The BioLife team will be onsite at booth 420. You must check out our NEW booth display, literature, and swag! 🙌

Come say hi to meet us for the first time or to catch up. We’re here to help you with biopreservation best practices, scaling up, CGT manufacturing challenges, and staying ahead of regulations.

This year’s agenda includes a new Investment Summit, Networking Concierge service, and more opportunities to connect than ever before!

➡️ Register soon: https://www.phacilitate.com/advanced-therapies-week

🧪 Are you a therapeutic/drug developer with an active clinical or pre-clinical pipeline? Request a FREE pass here: https://ow.ly/FAoJ50XSLxv

01/21/2026

As we mentioned yesterday, BioLife Solutions is proud to sponsor the ScaleReady G-Rex Grant Tour, which supports the Emily Whitehead Foundation.

If you are attending the Houston, TX kick-off event today (January 21), please make sure to visit the BioLife table. You’ll find Newton and Selley onsite and ready to meet you.

BioLife is providing product support and discounted access to tools and services for G-Rex Grant recipients to reduce development barriers. 🔬

Ask for the BioLife-ScaleReady flyer at our table! ✅

🚀 View details and the agenda: https://www.scaleready.com/concepts/g-rex-grant-tour-houston/

01/20/2026

We’re pleased to announce our partnership with ScaleReady and the Emily Whitehead Foundation to sponsor the G-Rex® Grant Tour, a year-long, 12-city initiative launching tomorrow, January 21, in Houston, TX. 🤝

The tour is designed to advance cell and gene therapy (CGT) manufacturing by delivering educational discussions, technical expertise, and scalable tools directly to researchers and developers across major U.S. CGT hubs. 🔬

We’re also thrilled that ScaleReady will support BioLife’s new Aby J. Mathew Center for Biopreservation Excellence by providing G-Rex® consumables, materials, and expertise to support process optimization and scale-up for clients.

📍Check out our latest news to find out more about the tour: https://www.biolifesolutions.com/resource-center/insights-blog/advancing-cell-gene-therapy-manufacturing-collaboration/